Top Markets
#1 MON MON +2,759.42%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +44.53%
#4 eCash eCash +32.94%
#5 Siren Siren +24.14%
#6 Janction Janction +19.65%
#7 SAFEcoin SAFEcoin +17.31%
#8 PinGo PinGo +15.88%
#9 Velvet Velvet +15.84%
#10 Decred Decred +12.95%
Coin of the day
MON MON
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Kedudukan dalam Saham #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Harga Saham
$0.30780727
Modal Pasaran
$94.19M
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
-34.73%
Negara
FR
Perdagangan Sensorion SA (ALSEN)

Kategori

Healthcare
Bilangan saham terbitan bagi Sensorion SA (ALSEN)
Bilangan saham terbitan setakat December 2025: 300.92M
Menurut laporan kewangan terkini dan harga saham Sensorion SA, bilangan saham terbitan semasa ialah 300.92M. Pada akhir December 2023, syarikat mempunyai 133.42M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Sensorion SA (ALSEN) dari 2011 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 300.92M 5.97%
2024 283.97M 112.83%
2023 133.42M 67.12%
2022 79.84M 0.18%
2021 79.69M 31.16%
2020 60.76M 225.81%
2019 18.65M 63.39%
2018 11.41M 58.34%
2017 7.21M 5.84%
2016 6.81M 59.47%
2015 4.27M 30.90%
2014 3.26M 0.00%
2013 3.26M 0.00%
2012 3.26M 0.00%
2011 3.26M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 1,376.33%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M -15.56%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M -65.44%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M -36.86%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -79.59%
NL